Even though some pancreatic cancer cells are resistant to the direct antiproliferation and cell death-inducing activities of IFN-α, such resistant cancer cells could be suppressed by the activation of the innate immune system, as shown in this study. This evidence concerns the gene IFNA1 and pancreatic neoplasm.